Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Minerva Neuroscie
(NQ:
NERV
)
2.343
+0.023 (+1.00%)
Streaming Delayed Price
Updated: 3:14 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Minerva Neuroscie
< Previous
1
2
3
4
5
6
Next >
5 Best Performing Micro-Cap Stocks Through the First Half of 2022
July 05, 2022
The first half of 2022 is finally in the books and it could not have come sooner. Major U.S. indices
Via
Spotlight Growth
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Epizyme + 20 Stocks Moving In Monday's Pre-Market Session
June 27, 2022
Gainers Tenax Therapeutics, Inc. (NASDAQ: TENX) rose 90.1% to $0.59 in pre-market trading after dipping more than 46% on Friday.
Via
Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
June 21, 2022
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,.
Via
Benzinga
Recap: Minerva Neurosciences Q1 Earnings
May 04, 2022
Minerva Neurosciences (NASDAQ:NERV) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
67 Biggest Movers From Yesterday
June 22, 2022
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital.
Via
Benzinga
24 Stocks Moving in Tuesday's Pre-Market Session
June 21, 2022
Gainers Valneva SE (NASDAQ: VALN) shares rose 83.6% to $25.18 in pre-market trading following Pfizer agreement to acquire an 8.1% stake.
Via
Benzinga
Minerva Outlines Next Steps For US Application For Schizophrenia Candidate
April 07, 2022
Minerva Neurosciences Inc (NASDAQ: NERV) received the
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
February 14, 2022
During Monday's session, 291 companies made new 52-week lows. Also check out this: Insiders Buying These 4 Penny Stocks Noteable 52-Week Lows And Highs: SAP (...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
June 10, 2022
Gainers bluebird bio (NASDAQ:BLUE) shares rose 53.4% to $6.12 during Friday's after-market session. Trading volume for this security closed at 5.0 million, accounting for 206.3% of its average full-day...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 03, 2022
Via
Benzinga
40 Stocks Moving In Friday's Mid-Day Session
June 03, 2022
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 25, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 21, 2022
Via
Benzinga
20 Stocks Moving Toward VWAP Breakout: GameStop, Roku, Moderna And More
March 29, 2022
Volume-weighted average price, or VWAP, is the ratio of total volume traded divided by the total volume traded for a chosen time frame. VWAP is an important indicator for intraday trading, as it...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 25, 2022
Gainers Tilray Brands (NASDAQ:TLRY) stock increased by 17.2% to $8.17 during Friday's pre-market session. The company's market cap stands at $3.9 billion. Sundial...
Via
Benzinga
Minerva Neurosciences: Q4 Earnings Insights
March 01, 2022
Minerva Neurosciences (NASDAQ:NERV) reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:30 AM. Here's what investors need to know about the announcement....
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 31, 2022
Gainers Oncternal Therapeutics (NASDAQ:ONCT
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 08, 2021
Gainers Autolus Therapeutics (NASDAQ:AUTL) stock rose 21.04% to $6.73 during Monday's pre-market session. The company's market cap stands at $490.7 million. As per...
Via
Benzinga
26 Stocks Moving in Monday's Pre-Market Session
November 08, 2021
Gainers Autolus Therapeutics plc (NASDAQ: AUTL) rose 32.6% to $7.37 in pre-market trading. Syncona said Blackstone Life Science will invest $250 million in Autolus. Mainz Biomed...
Via
Benzinga
Earnings Scheduled For November 8, 2021
November 08, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 25, 2021
Gainers Medpace Hldgs (NASDAQ:MEDP) shar...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 05, 2021
Gainers Ocugen (NASDAQ:OCGN) shares moved upwards by 11.11% to $7.5 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.4...
Via
Benzinga
15 Stocks Moving in Friday's Pre-Market Session
October 01, 2021
Gainers Progenity, Inc. (NASDAQ: PROG) rose 33% to $2.02 in pre-market trading after jumping over 40% on Thursday. Iterum Therapeutics plc (NASDAQ: ITRM) rose 25.1% to $0.6984...
Via
Benzinga
Minerva Posts Positive Bioequivalence Results For Schizophrenia Candidate Formulations
September 30, 2021
Minerva Neurosciences Inc (NASDAQ: NERV) announced results from a bioequivalence study comparing roluperidone formulations used in Phase 2b and Phase 3 trials and...
Via
Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...
Via
Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...
Via
Benzinga
22 Stocks Moving in Friday's Pre-Market Session
September 24, 2021
Gainers Focus Universal Inc. (NASDAQ: FCUV) rose 42% to $15.24 in pre-market trading. The company’s shares jumped around 65% over the previous month. vTv Therapeutics Inc...
Via
Benzinga
3 Downgraded Stocks to Sell in a Shaky Market
September 17, 2021
Over the last two weeks, the market has been steadily moving lower. There are increasing signs of economic stress in terms of supply chain issues, coronavirus case counts continuing to rise, and signs...
Via
Talk Markets
Exposures
COVID-19
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.